HLB Pharmaceutical has surpassed 100,000 interested customers on its Naver Brand Store.


HLB Pharma Surpasses 100,000 Interested Customers on Naver Brand Store View original image

As of August 10, HLB Pharmaceutical has been expanding the sales base for its health functional foods and consumer healthcare products, focusing on its Naver Brand Store. The company announced that reaching 100,000 interested customers will serve as a turning point to further strengthen the competitiveness of its online sales channels and enhance customer engagement.


HLB Pharmaceutical will hold a “Celebration Event for Reaching 100,000 Interested Customers” at its Naver Brand Store for seven days, from August 11 to 17. During this event, a 10% discount coupon will be offered on all products sold at the HLB Pharmaceutical Brand Store, with the exception of the continuous glucose monitor, Picoring. The coupon can be used for purchases of 100,000 won or more, with a maximum discount of 10,000 won.


Customer events will also be held based on the amount and frequency of purchases. The 10 customers with the highest purchase amounts will each receive a 50,000 won Baedal Minjok gift certificate, while the 5 customers with the most purchases will each receive three of HLB Pharmaceutical's best-selling products.


A review event will also be available for customers who write a review after making a purchase during the event period. Among those who write outstanding reviews, three first-place winners will receive 10,000 won in Naver Pay, and five second-place winners will receive 5,000 won in Naver Pay.



An official from HLB Pharmaceutical said, “Surpassing 100,000 interested customers was made possible by our customers’ continued interest and trust in our products and brand,” adding, “We will continue to introduce various products and benefits that help support consumers’ healthy daily lives.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing